References
Drasar, F. A., Farrell, W., Howard, A. J., Hince, C., Leung, T., Williams, J.: Activity of HR 756 againstHaemophilus influenzae, Bacteroides fragilis and gram-negative rods. Journal of Antimicrobial Chemotherapy 1978, 4: 445–450.
Hamilton-Miller, J. M. T., Brumfitt, W., Reynolds, A. B.: Cefotaxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro. Journal of Antimicrobial Chemotherapy 1978, 4: 437–444.
Neu, H. C., Aswapokee, N., Aswapokee, P., Kwung, P. F.: HR 756 a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1979, 15: 273–281.
Belohradsky, B., Bruch, K., Geiss, D., Kafetzis, D., Marget, W., Peters, G.: Intravenous cefotaxime in childten with bacterial meningitis. Lancet 1980, i: 61–63.
Reeves, O. S., Bywater, M. J.: Assay of microbiological agents. In: De Louvois, N. (ed.): Selected Topics in Clinical Bacteriology. Bailliere, Tindall, London, 1976, p. 21–78.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sachsenheimer, W., Kühner, A. Serum and cerebrospinal fluid levels of cefotaxime in neurosurgical patients. Eur. J, Clin. Microbiol. 3, 36–37 (1984). https://doi.org/10.1007/BF02032813
Issue Date:
DOI: https://doi.org/10.1007/BF02032813